Amalgamated Bank Cytom X Therapeutics, Inc. Transaction History

Amalgamated Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.53 - $2.89 $15,581 - $29,431	-10,184 Closed	0 $0
Q1 2022 Jun 30, 2022	SELL	$2.67 - $4.68 $2,184 - $3,828	-818 Reduced 7.44%	10,184 $27,000
Q4 2021 Feb 15, 2022	SELL	$3.87 - $7.39 $1,486 - $2,837	-384 Reduced 3.37%	11,002 $48,000
Q3 2021 Oct 29, 2021	SELL	$4.32 - $6.43 $1,710 - $2,546	-396 Reduced 3.36%	11,386 $58,000
Q2 2021 Aug 16, 2021	BUY	$6.33 - $9.91 $74,580 - $116,759	11,782 New	11,782 $75,000

50.4M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $58.7M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.